BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $828,000 | -4.4% | 10,295 | +2.4% | 0.03% | -53.2% |
| Q2 2020 | $866,000 | +5.4% | 10,054 | -0.7% | 0.06% | -13.9% |
| Q1 2020 | $822,000 | -0.5% | 10,129 | +2.6% | 0.07% | +30.9% |
| Q4 2019 | $826,000 | -3.7% | 9,873 | +0.7% | 0.06% | -12.7% |
| Q3 2019 | $858,000 | +7.0% | 9,805 | +0.2% | 0.06% | +5.0% |
| Q2 2019 | $802,000 | +48.8% | 9,790 | +47.7% | 0.06% | +46.3% |
| Q1 2019 | $539,000 | +19.0% | 6,628 | -3.8% | 0.04% | +2.5% |
| Q4 2018 | $453,000 | -16.4% | 6,887 | -2.0% | 0.04% | -11.1% |
| Q3 2018 | $542,000 | +3.2% | 7,027 | -1.2% | 0.04% | -6.2% |
| Q2 2018 | $525,000 | -0.9% | 7,112 | -12.8% | 0.05% | -4.0% |
| Q1 2018 | $530,000 | -4.8% | 8,153 | -5.4% | 0.05% | -7.4% |
| Q4 2017 | $557,000 | +6.9% | 8,620 | +3.8% | 0.05% | -5.3% |
| Q3 2017 | $521,000 | -1.1% | 8,307 | -4.6% | 0.06% | -8.1% |
| Q2 2017 | $527,000 | +266.0% | 8,704 | +213.5% | 0.06% | +210.0% |
| Q1 2017 | $144,000 | +21.0% | 2,776 | +3.9% | 0.02% | +11.1% |
| Q4 2016 | $119,000 | -22.2% | 2,673 | -16.7% | 0.02% | -25.0% |
| Q3 2016 | $153,000 | +0.7% | 3,207 | -4.6% | 0.02% | -4.0% |
| Q2 2016 | $152,000 | -38.0% | 3,360 | -43.6% | 0.02% | -41.9% |
| Q1 2016 | $245,000 | -38.8% | 5,962 | -43.2% | 0.04% | -41.9% |
| Q4 2015 | $400,000 | – | 10,488 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |